A US appeals court pauses the ITC's ban on Apple Watch Series 9 and Ultra 2 imports due to the Masimo patent dispute, after Biden declined to veto the ban
Apple (AAPL.O) scored a victory on Wednesday as a U.S. appeals court paused a government commission's import ban …
Context & Ripple Effects
The dispute escalated after the ITC refused to stay its own remedy while Apple pursued an appeal, and the administration then allowed that remedy to stand by declining a veto. The court pause interrupts enforcement without resolving the underlying patent fight.
The case matters because it tests how quickly an ITC exclusion order can affect a major consumer device when the challenged technology is tied to a specific health feature. Apple continued pressing for a merits reversal in its later appeal against the ITC ruling.
First-order effects
- Apple can continue importing the affected Watch models while the court's pause is in force, avoiding the immediate supply and sales disruption that the ITC remedy would have caused.
- Masimo's ITC win remains intact, but its ability to use the import ban as immediate enforcement leverage is suspended pending appellate review.
Second-order effects
- The pause gives Apple more time to pursue legal and product-based responses; later coverage showed that disabling pulse-oximetry could be treated as a route to sell a compliant Series 9, a feature-removal workaround that narrows the practical reach of an exclusion order.
- For Masimo and other patent holders, the sequence—from the ITC's refusal to stay the ban to a judicial pause—shows that winning an ITC remedy does not guarantee immediate market exclusion when appellate review is active.
Third-order effects
- If courts routinely pause exclusion orders during appeal, the ITC may remain a powerful patent-enforcement venue but become less reliable as a tool for forcing immediate commercial concessions.
- The dispute also points to a product-design reality for connected health features: modular software controls can become as consequential to patent remedies as the hardware at issue, subject to agency and court acceptance.
The trend: Patent disputes over feature-rich consumer devices are increasingly being fought through import remedies, appeals, and software changes rather than through damages claims alone.